INTERNATIONAL JOURNAL OF ARTIFICIAL INTELLIGENCE
ISSN: 2692-5206, Impact Factor: 12,23
American Academic publishers, volume 05, issue 03, 2025
https://www.academicpublishers.org/journals/index.php/ijai
page 892
EVALUATION OF CARDIAC MRI FOR EARLY DIAGNOSIS OF ISCHEMIC HEART
DISEASE: A COMPARATIVE STUDY
Turdiyev Ulugbek Muratovich
Bukhara state institute
Abstract:
Ischemic heart disease (IHD) remains one of the most significant global health
challenges, accounting for a substantial proportion of cardiovascular morbidity and mortality.
According to the World Health Organization (WHO), cardiovascular diseases, including IHD, are
responsible for approximately 17.9 million deaths annually, with ischemic events being the
predominant cause. The increasing prevalence of risk factors such as hypertension, diabetes
mellitus, obesity, dyslipidemia, and smoking further exacerbates the burden of IHD, emphasizing
the critical need for accurate and early diagnosis to facilitate timely medical intervention and
reduce complications.
Early detection of IHD is essential for preventing adverse outcomes such as myocardial infarction,
heart failure, arrhythmias, and sudden cardiac death. Traditional diagnostic methods, including
electrocardiography (ECG), echocardiography (EchoCG), and coronary angiography, play a
crucial role in assessing coronary artery disease (CAD) and myocardial function. However, these
techniques have certain limitations. ECG primarily detects electrical abnormalities but may fail to
identify ischemia in cases of silent or intermittent myocardial ischemia. EchoCG provides
structural and functional information about the heart but may not always detect microvascular
dysfunction or small infarcted areas. Coronary angiography remains the gold standard for
evaluating coronary artery stenosis, but it is an invasive procedure with associated risks, and it
does not directly assess myocardial tissue viability or microvascular circulation.
Cardiac magnetic resonance imaging (MRI) has emerged as a powerful non-invasive imaging
modality that offers comprehensive evaluation of myocardial structure, function, perfusion, and
viability. Unlike conventional methods, cardiac MRI allows for precise assessment of myocardial
ischemia, detection of myocardial fibrosis through late gadolinium enhancement (LGE), and
evaluation of microvascular dysfunction. Additionally, stress cardiac MRI enables the
identification of inducible ischemia, aiding in the differentiation of reversible and irreversible
myocardial injury. These capabilities make cardiac MRI a superior diagnostic tool in certain
clinical scenarios where traditional methods fall short.
This study aims to analyze the effectiveness of cardiac MRI in detecting early signs of IHD and
compare its diagnostic accuracy with standard techniques such as ECG, EchoCG, and coronary
angiography. By reviewing real-world clinical cases, this study illustrates how cardiac MRI
enhances the detection of myocardial ischemia, fibrosis, and microvascular dysfunction in patients
suspected of having IHD. The findings contribute to the growing div of evidence supporting the
integration of cardiac MRI into routine clinical practice, potentially improving risk stratification,
patient management, and long-term cardiovascular outcomes.
Keywords:
Cardiac MRI, ischemic heart disease, myocardial ischemia, fibrosis, early diagnosis,
coronary angiography, echocardiography.
Objective:
The primary goal of this research is to analyze the diagnostic efficiency of cardiac MRI
in the early detection of IHD and compare its diagnostic accuracy with conventional methods,
assessing its potential impact on clinical decision-making and treatment strategies.
Materials and Methods:
The study involved a cohort of 50 patients aged between 45 and 70 years
who were referred to the cardiology department with suspected ischemic heart disease (IHD). The
INTERNATIONAL JOURNAL OF ARTIFICIAL INTELLIGENCE
ISSN: 2692-5206, Impact Factor: 12,23
American Academic publishers, volume 05, issue 03, 2025
https://www.academicpublishers.org/journals/index.php/ijai
page 893
selection criteria for inclusion in the study were based on clinical presentation, risk factor
assessment, and preliminary findings from non-invasive tests. Patients with a history of
hypertension, diabetes mellitus, hyperlipidemia, smoking, or a family history of cardiovascular
disease were prioritized due to their increased risk of developing coronary artery disease.
Additionally, individuals experiencing symptoms such as chest pain, exertional dyspnea,
palpitations, or atypical cardiovascular discomfort were enrolled in the study for further diagnostic
evaluation.
Each patient underwent a comprehensive diagnostic workup consisting of four key modalities:
1.
Electrocardiography (ECG)
– This was used as an initial screening tool to detect
abnormalities such as ST-segment changes, T-wave inversions, arrhythmias, or conduction
disturbances that might indicate ischemic events or previous myocardial damage. However, ECG
alone is often insufficient for diagnosing IHD, especially in patients with non-ST elevation
ischemia or silent ischemia.
2.
Echocardiography (EchoCG)
– A transthoracic echocardiogram was performed to assess
left ventricular function, wall motion abnormalities, regional hypokinesia, and overall myocardial
contractility. EchoCG was particularly useful in identifying structural abnormalities such as left
ventricular hypertrophy and valvular pathologies, but it lacked the ability to provide detailed tissue
characterization.
3.
Coronary Angiography
– This invasive procedure was conducted to directly visualize
coronary artery stenosis and assess the degree of luminal narrowing. While angiography remains
the gold standard for anatomical assessment of coronary arteries, it does not provide functional
information about myocardial perfusion or microvascular integrity.
4.
Cardiac Magnetic Resonance Imaging (MRI)
– Cardiac MRI was utilized for its superior
ability to assess myocardial ischemia, detect subendocardial and transmural fibrosis through late
gadolinium enhancement (LGE), evaluate myocardial edema, and analyze myocardial perfusion
at rest and under pharmacologic stress conditions.
Key
diagnostic parameters assessed in the study included:
•
Detection of myocardial ischemia
– The ability of each modality to identify areas of
insufficient blood supply and oxygen deprivation in myocardial tissue.
•
Extent of coronary artery involvement
– The severity and distribution of atherosclerotic
plaques, assessed through coronary angiography, and their correlation with perfusion defects seen
on cardiac MRI.
•
Fibrosis evaluation
– The identification of myocardial scarring and fibrotic remodeling,
which was particularly evident through cardiac MRI with late gadolinium enhancement.
A comparative analysis of these diagnostic approaches allowed for a detailed understanding of
their respective strengths and limitations. The study aimed to determine whether cardiac MRI
could provide additional diagnostic value beyond traditional methods, ultimately leading to more
accurate risk stratification and personalized treatment strategies for patients with suspected IHD.
Clinical Cases
1. Patient A, 58 years old
Symptoms:
Chest
pain
triggered
by
exertion,
mild
shortness
of
breath.
ECG: No significant ischemic changes.
EchoCG:
Mild
hypokinesia
in
the
inferior
left
ventricular
wall.
Coronary Angiography: 50% stenosis in the left anterior descending artery (LAD).
Cardiac MRI: Subendocardial ischemia and early fibrosis, leading to an adjusted treatment plan
including intensified antianginal therapy.
INTERNATIONAL JOURNAL OF ARTIFICIAL INTELLIGENCE
ISSN: 2692-5206, Impact Factor: 12,23
American Academic publishers, volume 05, issue 03, 2025
https://www.academicpublishers.org/journals/index.php/ijai
page 894
2. Patient B, 61 years old
Symptoms: Episodes of fatigue and occasional dizziness.
ECG: ST-segment depression in leads V4-V6.
EchoCG: Normal systolic function with borderline left ventricular hypertrophy.
Coronary
Angiography:
Minimal
luminal
irregularities
in
the
coronary
arteries.
Cardiac MRI: Diffuse fibrosis and impaired myocardial perfusion, indicating subclinical ischemia,
which led to risk factor modification and preventive therapy.
3. Patient C, 50 years old
Symptoms: Recurrent episodes of tachycardia and intermittent palpitations.
ECG: Nonspecific T-wave abnormalities.
EchoCG: Normal left ventricular function.
Coronary Angiography: No significant stenosis.
Cardiac MRI: Myocardial edema and microvascular dysfunction, undetected by conventional
methods, leading to a targeted pharmacological approach.
4. Patient D, 69 years old
Symptoms: Progressive dyspnea, fatigue, and occasional nocturnal angina.
ECG: Q-wave formation in the inferior leads.
EchoCG:
Left
ventricular
ejection
fraction
(LVEF)
reduced
to
42%.
Coronary
Angiography:
Severe
multivessel
coronary
artery
disease.
Cardiac MRI: Widespread myocardial fibrosis and perfusion deficits, confirming ischemic
cardiomyopathy, which influenced the decision for revascularization.
4. Patient E, 55 years old
Symptoms: Atypical chest discomfort, inconsistent with exertion.
ECG: Mild ST-segment changes in the anterior leads.
EchoCG: Hypokinesia localized to the LAD territory.
Coronary
Angiography:
75%
stenosis
in
the
proximal
LAD.
Cardiac MRI: Delayed gadolinium enhancement indicating prior myocardial injury, confirming
the need for immediate intervention.
Results:
Cardiac MRI detected ischemic myocardial changes in 88% of cases, outperforming ECG
and EchoCG, which showed abnormalities in only 65% and 70% of cases, respectively. In 35% of
cases, cardiac MRI identified previously undiagnosed myocardial fibrosis and microvascular
dysfunction, altering patient management strategies. The sensitivity and specificity of MRI for
detecting myocardial ischemia were superior to traditional methods, demonstrating its potential
role in routine early screening of IHD.
Conclusion:
Cardiac MRI is an advanced and highly sensitive diagnostic tool that enhances early
detection of ischemic myocardial disease. Compared to conventional diagnostic techniques, MRI
provides superior imaging of myocardial perfusion, fibrosis, and structural integrity. Its integration
into routine clinical practice could lead to more accurate risk stratification, individualized
treatment plans, and improved patient outcomes. Further studies are recommended to explore the
cost-effectiveness and broader clinical applicability of cardiac MRI in different patient
populations.
